• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents.耐万古霉素肠球菌对新型抗菌药物的药敏模式
Indian J Med Res. 2015 Apr;141(4):483-6. doi: 10.4103/0971-5916.159309.
2
Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature.欧洲肠球菌中介唑林、替加环素和达托霉素耐药率的最新情况和耐药机制：走向通用命名法。
Drug Resist Updat. 2018 Sep;40:25-39. doi: 10.1016/j.drup.2018.10.002. Epub 2018 Nov 2.
3
In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.达托霉素、利奈唑胺和奎奴普丁-达福普汀对包括万古霉素中介金黄色葡萄球菌和万古霉素耐药粪肠球菌在内的葡萄球菌和肠球菌挑战组的体外活性。
Microb Drug Resist. 2003 Winter;9(4):389-93. doi: 10.1089/107662903322762833.
4
Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience.编者按：利奈唑胺与达托霉素治疗耐万古霉素肠球菌：试验与临床经验之间的证据差距
Clin Infect Dis. 2015 Sep 15;61(6):879-82. doi: 10.1093/cid/civ449. Epub 2015 Jun 10.
5
Clinical experience with recently approved antibiotics.近期获批抗生素的临床经验。
Curr Opin Pharmacol. 2006 Oct;6(5):486-90. doi: 10.1016/j.coph.2006.07.001. Epub 2006 Aug 9.
6
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.2004 年至 2009 年期间，在美国进行的替加环素评估和监测试验（TEST）中收集的革兰氏阳性分离株对替加环素和利奈唑胺的敏感性。
Clin Ther. 2011 Dec;33(12):1964-73. doi: 10.1016/j.clinthera.2011.10.010. Epub 2011 Nov 10.
7
Molecular typing, pathogenicity factor genes and antimicrobial susceptibility of vancomycin resistant enterococci in Belgrade, Serbia.塞尔维亚贝尔格莱德耐万古霉素肠球菌的分子分型、致病因子基因及抗菌药物敏感性
Acta Microbiol Immunol Hung. 2015 Jun;62(2):147-60. doi: 10.1556/030.62.2015.2.5.
8
Which antibiotic for hospital acquired pneumonia caused by MRSA?哪种抗生素可用于治疗由耐甲氧西林金黄色葡萄球菌（MRSA）引起的医院获得性肺炎？
BMJ. 2014 Feb 13;348:g1469. doi: 10.1136/bmj.g1469.
9
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.用于革兰氏阳性菌感染的抗生素：万古霉素、奎奴普丁-达福普汀、利奈唑胺和达托霉素。
Infect Dis Clin North Am. 2004 Sep;18(3):651-68, x. doi: 10.1016/j.idc.2004.04.014.
10
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.耐利奈唑胺和万古霉素的粪肠球菌心内膜炎：替加环素和达托霉素治疗成功
J Hosp Med. 2007 Sep;2(5):343-4. doi: 10.1002/jhm.236.

引用本文的文献

1
Riboflavin-Vancomycin Conjugate Enables Simultaneous Antibiotic Photo-Release and Photodynamic Killing against Resistant Gram-Positive Pathogens.核黄素-万古霉素共轭物可实现对抗耐药革兰氏阳性病原体的抗生素光释放和光动力杀伤同步进行。
JACS Au. 2023 Oct 24;3(11):3014-3023. doi: 10.1021/jacsau.3c00369. eCollection 2023 Nov 27.
2
Characterization of Vancomycin Resistant and Drug Ligand Interaction between of with the Bio-Compounds from .耐万古霉素特性以及[具体内容]与来自[具体来源]的生物化合物之间的药物配体相互作用
J Pharmacopuncture. 2023 Sep 30;26(3):247-256. doi: 10.3831/KPI.2023.26.3.247.
3
Vancomycin and Linezolid-Resistant Enterococcus Isolates from a Tertiary Care Center in India.来自印度一家三级医疗中心的耐万古霉素和利奈唑胺肠球菌分离株
Diagnostics (Basel). 2023 Mar 2;13(5):945. doi: 10.3390/diagnostics13050945.
4
Genotypic characterization of vancomycin-resistant causing urinary tract infection in northern India.印度北部万古霉素耐药导致尿路感染的基因型特征。
Indian J Med Res. 2022 Mar;155(3&4):423-431. doi: 10.4103/ijmr.IJMR_2554_19.
5
Prevalence and Antimicrobial Resistance of Species: A Retrospective Cohort Study in Italy.物种的患病率及抗菌药物耐药性：意大利的一项回顾性队列研究
Antibiotics (Basel). 2021 Dec 19;10(12):1552. doi: 10.3390/antibiotics10121552.
6
Biofilm Producing Isolates from Vaginal Microbiota.来自阴道微生物群的生物膜产生菌株。
Antibiotics (Basel). 2021 Sep 7;10(9):1082. doi: 10.3390/antibiotics10091082.
7
New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354.激酶抑制剂IMD0354对多重耐药革兰氏阳性菌的新型抗菌活性
Antibiotics (Basel). 2020 Oct 1;9(10):665. doi: 10.3390/antibiotics9100665.
8
Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit.耐万古霉素肠球菌肠道定植的危险因素：一项在三级儿科重症监护病房的前瞻性研究
J Lab Physicians. 2018 Jan-Mar;10(1):89-94. doi: 10.4103/JLP.JLP_32_17.

本文引用的文献

1
Vancomycin-resistant enterococci.耐万古霉素肠球菌。
Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006.
2
A current perspective on daptomycin for the clinical microbiologist.当前临床微生物学家视角下的达托霉素
Clin Microbiol Rev. 2013 Oct;26(4):759-80. doi: 10.1128/CMR.00030-13.
3
In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.在印度中部，从住院病例中分离出的耐甲氧西林金黄色葡萄球菌和万古霉素耐药肠球菌，评估达托霉素和利奈唑胺的体外活性。
Indian J Med Res. 2013 Jan;137(1):191-6.
4
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient.一名外科患者中与使用奥美拉唑相关的耐替加环素粪肠球菌。
J Antimicrob Chemother. 2012 Jul;67(7):1806-7. doi: 10.1093/jac/dks122. Epub 2012 Mar 27.
5
The rise of the Enterococcus: beyond vancomycin resistance.肠球菌的兴起：超越万古霉素耐药性。
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78. doi: 10.1038/nrmicro2761.
6
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.当前针对特定革兰阳性菌的抗菌治疗概念：耐甲氧西林金黄色葡萄球菌、耐青霉素肺炎链球菌和万古霉素耐药肠球菌。
Mayo Clin Proc. 2011 Dec;86(12):1230-43. doi: 10.4065/mcp.2011.0514.
7
Genetic basis for in vivo daptomycin resistance in enterococci.肠球菌体内达托霉素耐药的遗传基础。
N Engl J Med. 2011 Sep 8;365(10):892-900. doi: 10.1056/NEJMoa1011138.
8
Emergence of daptomycin-resistant VRE: experience of a single institution.万古霉素耐药肠球菌的出现：一家医疗机构的经验。
Infect Control Hosp Epidemiol. 2011 Apr;32(4):391-4. doi: 10.1086/659152.
9
Evaluation of tigecycline activity in clinical isolates among Indian medical centers.印度医疗中心临床分离株中替加环素活性的评估。
Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):734-7. doi: 10.4103/0377-4929.72061.
10
In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.达托霉素对与皮肤和软组织感染相关的金黄色葡萄球菌及耐万古霉素屎肠球菌分离株的体外活性：来自印度的初步结果
Diagn Microbiol Infect Dis. 2009 Oct;65(2):196-8. doi: 10.1016/j.diagmicrobio.2009.05.015.

Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents.

作者信息

Gupta Varsha, Singla Nidhi, Behl Preeti, Sahoo Tripti, Chander Jagdish

机构信息

Department of Microbiology, Government Medical College Hospital, Sector 32, Chandigarh 160 030, India.

出版信息

Indian J Med Res. 2015 Apr;141(4):483-6. doi: 10.4103/0971-5916.159309.

DOI:10.4103/0971-5916.159309
PMID:26112853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4510732/
Abstract
摘要